Thermo Fisher Scientific Inc. (TMO)

Market Cap	215.96B
Revenue (ttm)	43.74B
Net Income (ttm)	6.57B
Shares Out	377.61M
EPS (ttm)	17.32
PE Ratio	33.03
Forward PE	23.75
Dividend	$1.72 (0.30%)
Ex-Dividend Date	Sep 15, 2025

Volume	1,979,317
Open	567.90
Previous Close	567.20
Day's Range	562.38 - 578.24
52-Week Range	385.46 - 610.97
Beta	0.77
Analysts	Buy
Price Target	604.76 (+5.74%)
Earnings Date	Oct 22, 2025

About TMO

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: NYSE
• Ticker Symbol: TMO
• Website: https://www.thermofisher.com

Financial Performance

In 2024, Thermo Fisher's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Analyst Summary

According to 18 analysts, the average rating for TMO stock is "Buy." The 12-month stock price target is $604.76, which is an increase of 5.74% from the latest price.

Price Target

$604.76

(5.74% upside)

Analyst Consensus: Buy